Nanotech could improve protein delivery
Access Pharmaceuticals has signed an agreement with an unnamed US partner for a drug delivery system based on nanoparticle aggregates that can be used to formulate proteins that are degraded by solvents.
Archives for March 24, 2004
Novartis hangs back from Aventis bid
Switzerland's Novartis has confirmed that it is interested in joining with Aventis, but will not proceed with a formal bid unless the French government draws back from its hostile stance on a link-up, reports Phil Taylor.
India to get first protein manufacturing plant?
US-based biotechnology company Human Genome Sciences is planning to set up the first protein manufacturing facility in India in collaboration with local companies.
Depot for prostate cancer wins German OK
Debiopharm of Switzerland has won approval for a three-month depot formulation of Pamorelin (triptorelin pamoate), a drug to treat prostate cancer, based on its proprietary polymer-based drug delivery technology.